It is interesting. Why would a 50 year old on the short list for the CEO job suddenly announce his retirement?
ABBV STOCK HITS RECORD ALL TIME HIGH
- Thread starter anonymous
- Start date
-
- Tags
- None
The FDA approved Novartis/Sandoz's Myrimoz today.
Amgen launched AMGEVITA, in Europe last week.
Stocks taking a big hit, and will continue to free fall to $60s
Boom Boom
ABBV INC
$78.21 USD −DOWN $3.38 (4.14%)
My broker said if I buy ABBV, I’ll experience.........
Breaking news from Bernstein analyst Ronny Gal this afternoon on the Humira biosimilar fight in Europe: Abbvie has managed to win the first national biosimilars tender by agreeing to supply the product at a huge 80% discount to the brand’s existing price. Biosimilar discounts of more than 50% are not unusual in Europe, but 80% from the offset for the new Humira market is much steeper than expected. Abbvie’s aggressive move took its stock down 4%; executives had previously guided to a 20% drop in European Humira sales by the end of 2019, an estimate that is likely to be retracted on Friday when the company reports earnings
So Americans are being charged 80% more than Europeans for Humira ? Love DJT but Trump was a G damn fool to give corporate tax breaks which created little to no jobs BUT were used by Rick (and others) to buy back stock. Rick wants to gouge US patient population until 2023. This needs to addressed ASAP. The FDA in conjunction with the FTC are gonna rip Rick a new A hole. The SEC also is looking at several matters. Abbvie has had many consecutive beats on earnings and STILL tanked big time. I can see a street beat again on Friday BUT also watching for 6%-9% plunge. Reality has set in and the street knows ABBV is doomed. Rick put all his eggs in one basket and now Humira the life blood of Abbvie, is terminal. Ricks total compensation for 2018 will be slashed by 50%. This guy needs to be FIRED by BOD NOW!!!!
Opened at $84.19 currently in high $79s that’s a 5%+ drop after strong beat which is devastating news. You were correct sir on this scenario and the day is still young. If Abbv ends up anywhere in $70s range it’s lights out. I’ll second the fact that Richard needs to go.
Thanks to a stupid move by Trump, Abbvies Income tax expense in Q3 FELL $450 million from last years period. This is included and accounts for 40% of AbbVie's GAAP earnings year-over-year increase. Trump gave $450 MILLION to a company that is gouging American consumers. WTF !!!
AbbVie Inc
NYSE: ABBV
79.94 USD DOWN −0.100 (0.12%)
Nov 2
Why did Bill Chase announce his retirement? He is young. What is going on in the suite?
Because he knows Trump is coming after AbbVie's patent "estate."
Sad part is this is just another example of how big pharma exploits the flawed patent system and the weak antitrust enforcement, along with poor drug price regulation to ensure Americans pay out the ass compared to the rest of the world. The devious methods of our industrys greedy lawyers to circumvent the intent of current regulations is disgusting and we need comprehensive reforms.....But ONLY AFTER I make another $5M
I can't believe ABBV continues to fall, I hope it doesn't break below $85. It was like Aug2017 the last time it was that low.
Wow full-year performance of -18.50% .Where will the $2B+ Humira loss in EU be accounted for in other areas?. Looking at last 500 trades , 80% are 100 shares or less with the average sale is 47 shares. The shorts are working tape. Big BREAKING news coming in next 6-8 weeks.
AbbVie Inc
NYSE: ABBV
$79.97 USD −$5.94 DOWN (6.91%)
Last employee out turn out the lights....The Party's over.
AbbVie Inc
NYSE: ABBV
$79.97 USD −$5.94 DOWN (6.91%)
Last employee out turn out the lights....The Party's over.